ENVISTA HOLDINGS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.68 USD | -4.56% |
|
-2.67% | -18.20% |
| Apr. 29 | North American Morning Briefing : Investors Brace -2- | DJ |
| Apr. 26 | Morgan Stanley Downgrades Envista Holdings to Equalweight From Overweight, Cuts Price Target to $21 From $33 | MT |
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -18.20% | 3.54B | B- | ||
| -3.72% | 186B | C+ | ||
| -2.60% | 107B | C | ||
| -3.79% | 67.44B | A | ||
| +2.66% | 50.03B | B- | ||
| +16.39% | 47.81B | B- | ||
| +4.54% | 41.03B | B+ | ||
| +1.38% | 26.85B | B | ||
| +1.52% | 25.82B | A- | ||
| -1.17% | 25.01B | B |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- NVST Stock
- Ratings Envista Holdings Corporation
